Physician profile
Jesse Hatgis
NPI 1154666139
$90,078.57
in general payments reported to CMS, 2019-2025
41 companies · $35K in 2025
The $35K reported for 2025 was more than what 98% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,224 · 2020: $1,889 · 2021: $1,158 · 2022: $2,139 · 2023: $4,205 · 2024: $43K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $33K · Consulting Fee: $32K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $13K · Travel and Lodging: $4,032 · Honoraria: $591 · Education: $19.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32,745.17 |
| Consulting Fee | $32,150.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $13,131.15 |
| Travel and Lodging | $4,031.51 |
| Honoraria | $591.00 |
| Education | $19.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $42,741.76 | 2023-2025 | Prospera, Biotronik |
| Elliquence, LLC | $28,889.30 | 2024-2025 | Disc-Fx System |
| Abbott Laboratories | $5,865.47 | 2019-2024 | Proclaim |
| Spr Therapeutics, INC | $4,238.36 | 2019-2025 | Sprint Pns System |
| Zavation Medical Products, LLC | $1,515.88 | 2024 | |
| Nevro Corp. | $1,238.79 | 2020-2024 | Senza |
| Medtronic, INC. | $870.39 | 2023-2025 | Intellis Adaptivestim, Synchromedii |
| Collegium Pharmaceutical, INC. | $711.69 | 2020-2025 | Xtampza |
| Boston Scientific Corporation | $709.48 | 2019-2024 | Superion Indirect Decompression System |
| Pacira Pharmaceuticals Incorporated | $591.00 | 2023 | Exparel |
| Vertos Medical, INC. | $588.21 | 2020-2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $343.94 | 2025 | Evoke |
| Nalu Medical, INC. | $339.40 | 2021-2024 | Nalu Neurostimulation System |
| Electronic Waveform Lab, INC. | $176.29 | 2021-2024 | |
| Inspire Medical Systems, INC. | $134.54 | 2021 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Hatgis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.